Patent US1972839A successfully refreshed from Google Patents.
Patent US4681847A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4681847A Expired / Lapsed US ⏱️ 0.0 years remaining

Novel lysozyme-sensitive microorganism

Assignee: KH Neochem Co Ltd
•
Filing: 1985-01-28
•
Granted: 1987-07-21
•
Expires: 2005-01-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A novel lysozyme-sensitive microorganism belonging to the genus Corynebacterium or Brevibacterium and having a sensitivity to lysozyme at a concentration of less than 25 μg/ml is provided from selected mutants. This novel microorganism is especially suitable for use in recombinant DNA technology.

Inventors

  • 👤 Ryoichi Katsumata
  • 👤 Tetsuo Oka
  • 👤 Akira Furuya

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 09:16
CPC Classifications
C; C12; C12N; C12N1/00; C12N1/20; C12N1/205; C12N15/00; C12N15/09; C12N15/63; C12N15/74; C12N15/77; C12R; C12R2001/00; C12R2001/01; C12R2001/13; C12R2001/15; Y; Y10; Y10S; Y10S435/00; Y10S435/8215; Y10S435/822; Y10S435/84; Y10S435/843

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 105 words
A biologically pure culutre of a novel lysozyme-sensitive microorganism obtained by mutation treatment of a microorganism belonging to the genus Corynebacterium or Brevibacterium, having a sensitivity to lysozyme, having the ability to be converted to protoplast by treatment with lysozyme to remove the cell wall without pretreatment with an antibiotic and having an efficient transformation ability due to the high regenerating ability of the protoplast, wherein the lysozyme-sensitive microorganism is selected from the group consisting of Corynebacterium glutamicum L-15 (FERM P-5946, ATCC 31834), Corynebacterium hercules L-103 (FERM P-5947, ATCC 31866), Brevibacterium divaricatum L-204 (FERM P-5948, ATCC 31867) and Brevibacterium lactofermentum L-312 (FERM P-5949, ATCC 31868).
Claim 2
Dependent Claim 105 words
A biologically pure culutre of a novel lysozyme-sensitive microorganism obtained by mutation treatment of a microorganism belonging to the genus Corynebacterium or Brevibacterium, having a sensitivity to lysozyme, having the ability to be converted to protoplast by treatment with lysozyme to remove the cell wall without pretreatment with an antibiotic and having an efficient transformation ability due to the high regenerating ability of the protoplast, wherein the lysozyme-sensitive microorganism is selected from the group consisting of Corynebacterium glutamicum L-15 (FERM P-5946, ATCC 31834), Corynebacterium hercules L-103 (FERM P-5947, ATCC 31866), Brevibacterium divaricatum L-204 (FERM P-5948, ATCC 31867) and Brevibacterium lactofermentum L-312 (FERM P-5949, ATCC 31868).
Claim 3
Dependent Claim 127 words
A process for preparing a protoplast of a microorganism belonging to the genus Corynbascterium or Brevibacterium, which comprises treating a lysozyme-sensitive microorganism obtained by mutation treatment of a microorganism belonging to the genus Corynebacterium or Brevibacterium, having a sensitivity to lysozyme, having the ability to be converted to protoplast by treatment with lysozyme to remove the cell wall without pretreatment with an antibiotic and having an efficient transformation ability due to the high regenerating ability of the protoplast, with lysozyme to form a protoplast of the microorganism, wherein the lysozyme-sensitive microorganism is selected from the group consisting of Corynbacterium glutamicum L-15 (FERM P-5946, ATCC 31834), Corynbacterium herculis L-103 (FERM P-5947, ATCC 31866), Brevibacterium divaricatum L-204 (FERM P-5948, ATCC 31867) and Brevibacterium lactofermentum L-312 (FERM P-5949, ATCC 31868).
Claim 4
Dependent Claim 127 words
A process for preparing a protoplast of a microorganism belonging to the genus Corynbascterium or Brevibacterium, which comprises treating a lysozyme-sensitive microorganism obtained by mutation treatment of a microorganism belonging to the genus Corynebacterium or Brevibacterium, having a sensitivity to lysozyme, having the ability to be converted to protoplast by treatment with lysozyme to remove the cell wall without pretreatment with an antibiotic and having an efficient transformation ability due to the high regenerating ability of the protoplast, with lysozyme to form a protoplast of the microorganism, wherein the lysozyme-sensitive microorganism is selected from the group consisting of Corynbacterium glutamicum L-15 (FERM P-5946, ATCC 31834), Corynbacterium herculis L-103 (FERM P-5947, ATCC 31866), Brevibacterium divaricatum L-204 (FERM P-5948, ATCC 31867) and Brevibacterium lactofermentum L-312 (FERM P-5949, ATCC 31868).
Claim 5
Dependent Claim 129 words
A process for transforming a microorganism belonging to the genus Corynbascterium or Brevibacterium, which comprises treating a microorganism obtained by mutation treatment of a microorganism belonging to the genus Corynebacterium or Brevibacterium, having a sensitivity to lysozyme, having the ability to be converted to protoplast by treatment with lysozyme to remove the cell wall without pretreatment with an antibiotic and having an efficient transformation ability due to the high regenerating ability of the protoplast with lysozyme; introducing deoxyribonucleic acid into the protoplast; and regenerating the protoplast to normal cells, wherein the lysozyme-sensitive microorganism is selected from the group consisting of Corynbacterium glutamicum L-15 (FERM P-5946, ATCC 31834), Corynebascterium herculis L-103 (FERM P-5947, ATCC 31866), Brevibacterium divaricatum L-204 (FERM P-5948, ATCC 31867) and Brevibacterium lactofermentum L-312 (FERM P-5949, ATCC 31868).
Claim 6
Dependent Claim 129 words
A process for transforming a microorganism belonging to the genus Corynbascterium or Brevibacterium, which comprises treating a microorganism obtained by mutation treatment of a microorganism belonging to the genus Corynebacterium or Brevibacterium, having a sensitivity to lysozyme, having the ability to be converted to protoplast by treatment with lysozyme to remove the cell wall without pretreatment with an antibiotic and having an efficient transformation ability due to the high regenerating ability of the protoplast with lysozyme; introducing deoxyribonucleic acid into the protoplast; and regenerating the protoplast to normal cells, wherein the lysozyme-sensitive microorganism is selected from the group consisting of Corynbacterium glutamicum L-15 (FERM P-5946, ATCC 31834), Corynebascterium herculis L-103 (FERM P-5947, ATCC 31866), Brevibacterium divaricatum L-204 (FERM P-5948, ATCC 31867) and Brevibacterium lactofermentum L-312 (FERM P-5949, ATCC 31868).
Claim 7
Dependent Claim 113 words
A process which comprises using a microorganism obtained by mutation treatment of a microorganism belonging to the genus Corynebacterium or Brevibacterium, having a sensitivity to lysozyme, having the ability to be converted to protoplast by treatment with lysozyme to remove the cell wall without pretreatment with an antibiotic and having an efficient transformation ability due to the high regenerating ability of the protoplast, as a host in introducing a DNA into the microorganism, wherein the lysozyme-sensitive microrganism is selected from the group consisting of Corynbacterium glutamicum L-15 (FERM P-5946, ATCC 31834), Corynebacterium herculis L-103 (FERM P-5947, ATCC 31866), Brevibacterium divaricatum L-204 (FERM P-%(48, ATCC 31867) and Brevibacterium lactofermentum L-312 (FERM P-5949, ATCC 31868).
Claim 8
Dependent Claim 113 words
A process which comprises using a microorganism obtained by mutation treatment of a microorganism belonging to the genus Corynebacterium or Brevibacterium, having a sensitivity to lysozyme, having the ability to be converted to protoplast by treatment with lysozyme to remove the cell wall without pretreatment with an antibiotic and having an efficient transformation ability due to the high regenerating ability of the protoplast, as a host in introducing a DNA into the microorganism, wherein the lysozyme-sensitive microrganism is selected from the group consisting of Corynbacterium glutamicum L-15 (FERM P-5946, ATCC 31834), Corynebacterium herculis L-103 (FERM P-5947, ATCC 31866), Brevibacterium divaricatum L-204 (FERM P-%(48, ATCC 31867) and Brevibacterium lactofermentum L-312 (FERM P-5949, ATCC 31868).
Claim 9
Dependent Claim 109 words
A biologically pure culture of a novel lysozyme-sensitive microorganism obtained by mutation treatment of a microroganism belonging to the genus Corynbacterium or Brevibacterium, having a sensitivity to lysozyme, having the ability to be converted to protoplast by treatment with lysozyme to remove the cell wall without pretreatment with an antibiotic and having an efficient transformation ability due to the high regenerating ability of the protoplast, and carrying pCG4 plasmid, wherein the lysozyme-sensitive microorganism is selected from the group consisting of Corynebacterium glutamicum L-15/pCG4 (FERM P-595), ATCC 31835), Corynbacterium herculis L-103/pCG4 (FERM P-5951, ATCC 31869), Brevibacterium divaricatum L-204/pCG4 (FERM P-5950, ATCC 31870) and Brevibacterium lactofermentum L-312/pCG4 (FERM P-5953, ATCC 31871).
Claim 10
Dependent Claim 109 words
A biologically pure culture of a novel lysozyme-sensitive microorganism obtained by mutation treatment of a microroganism belonging to the genus Corynbacterium or Brevibacterium, having a sensitivity to lysozyme, having the ability to be converted to protoplast by treatment with lysozyme to remove the cell wall without pretreatment with an antibiotic and having an efficient transformation ability due to the high regenerating ability of the protoplast, and carrying pCG4 plasmid, wherein the lysozyme-sensitive microorganism is selected from the group consisting of Corynebacterium glutamicum L-15/pCG4 (FERM P-595), ATCC 31835), Corynbacterium herculis L-103/pCG4 (FERM P-5951, ATCC 31869), Brevibacterium divaricatum L-204/pCG4 (FERM P-5950, ATCC 31870) and Brevibacterium lactofermentum L-312/pCG4 (FERM P-5953, ATCC 31871).

References Cited (Backward Citations)

US4237224A Cited
US4346169A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-07-20 1991-01-19 1991-07-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-07-20 1995-01-19 1995-07-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-07-20 1999-01-19 1999-07-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag